Linyi Cancer Hospital — Linyi, Shandong

Public research footprint of Linyi Cancer Hospital, compiled from the ClinicalTrials.gov public registry.

175

Registered studies

116

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Non-Small Cell Lung Cancer · Carcinoma, Non-Small-Cell Lung · Extensive-stage Small Cell Lung Cancer (ES-SCLC) · Breast Neoplasms

Recently updated registry entries

NCT06952504 — A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab… (Recruiting)
NCT06841354 — A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination… (Recruiting)
NCT06459180 — A Study to Compare Sacituzumab Tirumotecan (MK-2870) Monotherapy Versus Treatment of… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Linyi Cancer Hospital?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.